Stay up to date on all things ATS 2025 International Conference. Check out latest news, key deadlines, and exciting program updates below. Don’t miss a beat… and see you in San Francisco, May 16-21, 2025!
-
Advocate and Public Speaker to Recount Journey of Resilience During ATS 2025 Plenary Session
on 2025-04-11Len Geiger will be the keynote speaker during the Plenary Session at the ATS 2025 International Conference. After making an incredible recovery from Alpha-1 antitrypsin deficiency, Mr. Geiger has emerged as a national voice for rare disease advocacy, connecting with audiences nationwide. He will share his compelling story of resilience, hope, and the profound connections that can transform the lives of patients and their care teams with International Conference attendees in San Francisco.
-
Public Advisory Roundtable Prioritizes the Patient at ATS 2025
on 2025-04-11The annual Patients & Experts Forum will be held on Saturday, May 17, at the InterContinental Hotel in San Francisco. The patient and family education event is free to attend at ATS 2025 San Francisco. This year’s theme is “Personalized Medicine in Pulmonary Care – What it Means to be the Patient.”
-
ATS International Participants Center Connects Global Health Specialists Around the World
on 2025-04-11The International Participants Center unites international and U.S.-based attendees who share a vested interest in global health. The IPC will be open Sunday, May 18, through Tuesday, May 20, in Hall D of the Moscone Center.
-
ATS 2025 Program Explores the Importance of Increasing Vaccine Adoption
on 2025-04-11The ATS is one of seven health specialty societies to be awarded a grant from the Council of Medical Specialty Societies and CDC to increase national vaccination rates among high-risk adult patients. ATS 2025 San Francisco will feature numerous educational opportunities that explore strategies to further this initiative to improve patient health.
-
ATS 2025 Advocacy Efforts Offer Attendees the Chance to Offset Travel Carbon Emissions
on 2025-04-11Those traveling to ATS 2025 San Francisco can help offset the carbon emissions generated by their travel to and from the conference by opting for a renewable energy credit add-on to their registration. In 2024, the Society was able to purchase over 2,000 renewable energy credits thanks to conference attendees.
-
ATS Professional Assemblies to Meet at International Conference
on 2025-04-11The 14 Assemblies of the ATS will hold membership meetings in San Francisco on Sunday, May 18, and Monday, May 19, during the International Conference. All meetings will take place in the Moscone West Building.
-
Support Local Businesses While Exploring San Francisco at ATS 2025
on 2025-04-11The ATS prioritizes the promotion of local, diverse-owned businesses to support the local economies of the International Conference host cities. For ATS 2025, the Society has collaborated with numerous diverse-owned businesses for attendees to enjoy during their stay in The Bay.
-
Camp ATS Provides Care for Kids at ATS 2025 San Francisco
on 2025-04-11For attendees who would like to make their stay in San Francisco a family affair, Camp ATS is the place for kids ages six months to 12 years to enjoy their day while their parents are engaged during the day at the Moscone Center from Friday, May 16, to Wednesday, May 21. Registration is open now!
-
Explore the Latest Research and Clinical Guidelines for Bronchiectasis at ATS 2025
on 2025-03-28Despite the complexities of managing and treating bronchiectasis, recent research developments provide reasons for optimism. The FDA has set Aug. 12 as an action date for its review of brensocatib, which has the potential to be the first FDA-approved medication for bronchiectasis. Dan Belz, MD, MPH, spoke with ATS Conference News about how these developments, and more, will be discussed extensively at the ATS 2025 International Conference.
-
ATS 2025 Program Tackles Advancements and Pressing Challenges with COPD
on 2025-03-28According to the World Health Organization, chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death globally, accounting for approximately five percent of deaths worldwide in 2021. The ATS International Conference is a rare opportunity for health specialists from around the globe to share insights and collectively address the most prevalent challenges in respiratory medicine. Christopher Mosher, MD, MHS, highlighted several key sessions exploring critical aspects of COPD.